Skip to main content
Log in

Thrombolytic Therapy in Acute Myocardial Infarction

A Perspective

  • Section 1: Introduction to Thrombolysis in Acute Myocardial Infarction
  • Published:
Drugs Aims and scope Submit manuscript

Summary

This paper deals with the history of thrombolytic therapy from its inception to its application in acute myocardial infarction. It describes the discovery of streptococcal fibrinolysin, followed by the elucidation of the plasma proteolytic enzyme system concerned with fibrinolysis. An outline is given of the therapeutic basis for the decision to concentrate on the development of activators of the enzyme, rather than the enzyme itself. Early attempts to demonstrate the value of streptokinase and urokinase in the treatment of myocardial infarction are examined. Finally, the more encouraging approaches in current use, especially the early application of thrombolytic therapy after the onset of the morbid event, are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aber CP, Bass NM, Berry CL, et al. Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom. British Medical Journal 11: 1100–1104, 1976

    Google Scholar 

  • Alderman EL, Jutsy KR, Berte LE, Miller RE, Friedman JP, et al. Randomized comparison of intravenous versus intracoronary streptokinase for myocardial infarction. American Journal of Cardiology 54: 14–19, 1984

    PubMed  CAS  Google Scholar 

  • Alkjaersig N, Fletcher AP, Sherry S. The mechanism of clot dissolution by plasmin. Journal of Clinical Investigation 38: 1086–1095, 1959

    PubMed  CAS  Google Scholar 

  • Amery A, Roeber G, Vermuelen HJ, Verstraete M. Single-blind randomized trial comparing heparin and streptokinase treatment in recent myocardial infarction. Acta Medica Scandinavica (Suppl.) 505: 5–35, 1967

    Google Scholar 

  • Anderson JL, Marshall HW, Bray BE, Lutz JR, Frederick PR, et al. A randomised trial of intracoronary streptokinase in the treatment of acute myocardial infarction. New England Journal of Medicine 308: 1312–1318, 1983.

    PubMed  CAS  Google Scholar 

  • Australian Multicentre Trial of Streptokinase in Acute Myocardial Infarction. Medical Journal of Australia 1: 553, 1977

    Google Scholar 

  • Benda V, Haider M, Ambrosch P. Ergebnisse der Osterreichen Herzinfarkt Studie mit Streptokinase. Results of the Austrian myocardial infarction study of the effects of streptokinase. Klinische Wochenschrift 89: 779–783, 1977

    CAS  Google Scholar 

  • Bett JHN, Biggs JC, Castaldi PA, et al. Australian multicentre trial of streptokinase in acute myocardial infarction. Lancet 2: 57–60, 1973

    Google Scholar 

  • Breddin K, Ehrly AM, Fechler L, et al. Die Kurzzeit-fibrinolyse beim akuten Myokardinfarkt. Deutsche Medizin Wochenschrift 98: 861–873, 1973

    CAS  Google Scholar 

  • Brochier M, Raynaud R, Planiol T, et al. Le traitement par l’urokinase des infarctus de myocarde et syndromes de menace. Etude randomisée de 120 cas. Archives Mal Coeur 68: 563, 1975

    CAS  Google Scholar 

  • Chandler AB, Chapman I, Erhardt L, Roberts WC, Schwartz CJ, et al. Coronary thrombosis in myocardial infarction. American Journal of Cardiology 34: 823–832, 1974

    PubMed  CAS  Google Scholar 

  • Christensen LR. The mechanism of streptococcal fibrinolysis. Journal of Bacteriology (Abstract) 47: 471–472, 1944

    Google Scholar 

  • Christensen LR. Streptococcal fibrinolysis: A proteolytic reaction due to a serum enzyme activated by streptococcal fibrinolysis. Journal of General Physiology 28: 363–383, 1945

    PubMed  CAS  Google Scholar 

  • Christensen LR. The activation of plasminogen by chloroform. Journal of General Physiology 30: 149–157, 1946

    PubMed  CAS  Google Scholar 

  • Christensen LR, MacLeod CM. A proteolytic enzyme of serum: characterization, activation, and reaction with inhibitors. Journal of General Physiology 28: 559–583, 1945

    PubMed  CAS  Google Scholar 

  • Cliffton EE, Cannamela DA, Grossi C. In vivo studies of human plasmin. Intravenous injection in dogs and rabbits. Journal of Applied Physiology 6: 143–150, 1953

    CAS  Google Scholar 

  • Collen D. On the regulation and control of fibrinolysis. Thrombosis and Haemostasis 45: 77–89, 1981

    Google Scholar 

  • Cowley MJ, Hastillo A, Vetrovec GW, Fisher LM, Garrett R, et al. Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency. Circulation 67: 1031–1038, 1983

    PubMed  CAS  Google Scholar 

  • Cribier A, Berland J, Champoud O, Moore N, Behar P, et al. Intracoronary thrombolysis in evolving myocardial infarction. Sequential angiographic analysis of left ventricular performance. British Heart Journal 50: 401–410, 1983

    PubMed  CAS  Google Scholar 

  • Dastre A. Fibrinolyse dans le sang. Archives de Physiologie Normales et Pathologique 5: 661, 1893

    Google Scholar 

  • Davies MC, Englert ME, DeRenzo EC. Interaction of streptokinase and human plasminogen. I. Combining of streptokinase and plasminogen observed in the ultracentrifuge under a variety of experimental conditions. Journal of Biological Chemistry 239: 2651–2656, 1964

    PubMed  CAS  Google Scholar 

  • Delezene C, Pozerski E. Action du serum sanguin sur la gelatine en presence du chloroforme. Comptes Rendus des Seances de la Biologie et de Ses Filiales (Paris) 55: 327, 1903a

    Google Scholar 

  • Delezene C, Pozerski E. Action kinasique du serum sanguin prealablement traite par le chloroforme. Comptes Rendus des Seances de la Société de Biologie et de Ses Filiales (Paris) 55: 693, 1903b

    Google Scholar 

  • Denis PS. Essai sur l’application de la chimie a l’etude physiologique du sang de l’homme, et a l’etude physiologico — pathologique, hygienique et therapeutique des maladies de cette humeur. Bechet jne., p. 336 Paris, 1838

    Google Scholar 

  • Denys J, Marbaix H De. Les peptonisations provoquées par le chloroforme. Cellule 5: 197, 1889

    Google Scholar 

  • Dewar HA, Stephenson P, Horler AR, et al. Fibrinolytic therapy of coronary thrombosis. Controlled trial of 75 cases. British Medical Journal 1: 915–920, 1963

    CAS  Google Scholar 

  • DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. New England Journal of Medicine 303: 897–902, 1980

    PubMed  CAS  Google Scholar 

  • Dioguardi N, Mannucci PM, Lotto A, et al. Controlled trial of streptokinase and heparin in acute myocardial infarction. Lancet 2: 891–895, 1971

    PubMed  CAS  Google Scholar 

  • European Collaborative Study. Controlled trial of urokinase in myocardial infarction. Lancet 2: 624–626, 1975

    Google Scholar 

  • European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator. Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Lancet 1: 842–847, 1985

    Google Scholar 

  • European Cooperative Study Group for Streptokinase Treatment in Acute Myocardial Infarction. Streptokinase in acute myocardial infarction. New England Journal of Medicine 301: 797–802, 1979

    Google Scholar 

  • European Cooperative Study Group. Streptokinase in Acute Myocardial Infarction. Extended report of the European Cooperative trial. Acta Medica Scandinavica (Suppl.) 648: 7–57, 1981

    Google Scholar 

  • European Working Party. Streptokinase in recent myocardial infarction: a controlled multicentre trial. British Medical Journal 3: 325–331, 1971

    Google Scholar 

  • Fleisher MS, Loeb L. On tissue fibrinolysis. Journal of Biological Chemistry 21: 477, 1915

    CAS  Google Scholar 

  • Fletcher AP, Alkjaersig N, Smyrniotis FE, Sherry S. The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Transactions Association of American Physicians 71: 287–296, 1958

    CAS  Google Scholar 

  • Fletcher AP, Alkjaersig N, Sherry S. The maintenance of a sustained thrombolytic state in man. I. Induction and effects. Journal of Clinical Investigation 38: 1096–1110, 1959a

    PubMed  CAS  Google Scholar 

  • Fletcher AP, Sherry S, Alkjaersig N, Smyrniotis FF, Jick S. The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thrombo embolic disorders. Journal of Clinical Investigation 38: 1111–1119, 1959b

    PubMed  CAS  Google Scholar 

  • Fletcher AP, Alkjaersig N, Sherry S, Genton E, Hirsh J, et al. The development of urokinase as a thrombolytic agent. Maintenance of a sustained thrombolytic state in man by its intravenous infusion. Journal of Laboratory and Clinical Medicine 65: 713–738, 1965

    PubMed  CAS  Google Scholar 

  • Frank (Zielinski) B. Traitement de l’infarctus du myocarde par la streptokinase. These pour le Doctorat en Medecine, Faculte de Medecine, Bichat-Beaujon Universite Paris VII, 1975

  • Ganz W, Buchbinder N, Marcus H, Mondkar A, Maddahi J, et al. Intracoronary thrombolysis in evolving myocardial infarction. American Heart Journal 101: 4–13, 1981

    PubMed  CAS  Google Scholar 

  • Ganz W, Geft I, Shah PK, Lew AS, Rodriguez L, et al. Intravenous streptokinase in evolving acute myocardial infarction. American Journal of Cardiology 53: 1209–1216, 1984

    PubMed  CAS  Google Scholar 

  • Garner RL, Tillett WS. Biochemical studies on the fibrinolytic activity of hemolytic streptococci I. Isolation and characterization of fibrinolysin. Journal of Experimental Medicine 60: 239–254, 1934a

    PubMed  CAS  Google Scholar 

  • Garner RL, Tillett WS. Biochemical studies on the fibrinolytic activity of hemolytic streptococci II. Nature of the reaction. Journal of Experimental Medicine 60: 255–267, 1934b

    PubMed  CAS  Google Scholar 

  • Goldberg S, Urban PL, Greenspon A, Lebenthal M, Walinsky P, et al. Combination therapy for evolving myocardial infarction: Intracoronary thrombolysis and percutaneous transluminal angioplasty. American Journal of Medicine 72: 994–997, 1982

    PubMed  CAS  Google Scholar 

  • Gormsen J, Tidstrom B, Feddersen C, et al. Biochemical evaluation of a low dose of urokinase in acute myocardial infarction. A double-blind study. Acta Medica Scandinavica 194: 191–198, 1973

    PubMed  CAS  Google Scholar 

  • Gormsen J, Fletcher AP, Alkjaersig N, Sherry S. The enzymatic lysis of plasma clots: the influence of fibrin stabilization on lysis rates. Archives of Biochemistry and Biophysics 120: 654–655, 1967

    CAS  Google Scholar 

  • Gruppo Italiano Per Lo Studio Delia Streptochinasi Nell’Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1: 397–401, 1986

    Google Scholar 

  • Heikenheimo R, Ahrenberg P, Honkapohja H, et al. Fibrinolytic treatment in acute myocardial infarction. Acta Medica Scandinavica 189: 7–13, 1971

    Google Scholar 

  • Hiemeyer V, (Ed). Therapeutische and Experimentelle Fibrinolyse. Proceedings of International Symposium, FK Schattauer, Stuttgart, New York, 1969

    Google Scholar 

  • Hirsh J. The use of anticoagulation in patients treated with streptokinase. In New Concepts of Streptokinase Dosimetry. Martin et al. (Eds) pp 135–140, Hans Huber, Bern-Stuttgart-Vienna, 1978

    Google Scholar 

  • ISAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days. New England Journal of Medicine 314: 1465–1471, 1986

    Google Scholar 

  • Johnson AJ, McCarty WR. The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase. Journal of Clinical Investigation 38: 1627–1643, 1959

    PubMed  CAS  Google Scholar 

  • Johnson AJ, Tillett WS. Lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase). Journal of Experimental Medicine 95: 449–464, 1952

    PubMed  CAS  Google Scholar 

  • Kaplan MH. Nature and role of the lytic factor in hemolytic streptococcal fibrinolysis. Proceedings Society of Experimental Biology and Medicine 57: 40–43, 1944

    CAS  Google Scholar 

  • Klein W, Pavek P, Brandt D, et al. Resultate einer Doppelblindstudie beim Myokardinfarkt. In: Sailer S. (ed) Die Fibrinolysebehandlung des akuten Myokardinfarktes. Verlag Bruder Hollinek, pp. 65–73, Vienna, 1976

    Google Scholar 

  • Kline DL. Purification and crystallization of plasminogen (profibrinolysin). Journal of Biological Chemistry 204: 949–955, 1953

    PubMed  CAS  Google Scholar 

  • Koren G, Weiss AT, Hasin Y, Appelbaum D, Welber S, et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. New England Journal of Medicine 313: 1384–1389, 1985

    PubMed  CAS  Google Scholar 

  • Lasierra C, Vilades J, Fernandez C, et al. Estreptoquinasa en el infarto agudo de miocardio. Revista Clinica Espanola 144: 251–257, 1977

    Google Scholar 

  • Lee G, Amsterdam EA, Low R, Joye JA, Kimchi A, DeMaria AN and Mason DT. Efficacy of percutaneous transluminal coronary revascularization utilizing streptokinase thrombolysis in patients with acute myocardial infarction. American Heart Journal 102: 1159–1167, 1981

    PubMed  CAS  Google Scholar 

  • Lippschultz EJ, Ambras JL, Ambras CM, et al. Controlled study on the treatment of coronary occlusion with urokinase-activated human plasmin. American Journal of Cardiology 16: 93–98, 1965

    Google Scholar 

  • MacFarlane RG, Biggs R. Fibrinolysis. Its mechanism and significance. Blood 3: 1167–1187, 1948

    CAS  Google Scholar 

  • Markis JE, Malagold M, Parker A, Silverman KJ, Barry WH, et al. Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction. New England Journal of Medicine 305: 777–782, 1981

    PubMed  CAS  Google Scholar 

  • Martin M, Schoop W, Hirsh J. (Eds) New Concepts in Streptokinase Dosimetry. Hans Huber, Bern-Stuttgart-Vienna, 1978

    Google Scholar 

  • Mathey DG, Kuck KH, Tilsner V, Krebber HJ, Bleifeld W. Nonsurgical coronary artery recanalisation in acute transmural myocardial infarction. Circulation 63: 489–497, 1981

    PubMed  CAS  Google Scholar 

  • Mayer G, Story WE, Seco JE, Nocero Jr MA. Myocardial infarction management with peripheral streptokinase. Annals of Emergency Medicine 13: 1000–1007, 1984

    PubMed  CAS  Google Scholar 

  • Merx W, Dorr R, Rentrop P, Blanke H, Karsch KR, et al. Evaluation of the effectiveness of intracoronary streptokinase infusion in myocardial infarction: postprocedure management and hospital course in 204 patients. American Heart Journal 102: 1181–1187, 1981

    PubMed  CAS  Google Scholar 

  • Milstone H. A factor in normal human blood which participates in streptococcal fibrinolysis. Journal of Immunology 42: 109–116, 1941

    CAS  Google Scholar 

  • Mullertz S, Lassen M. An activator system in blood indispensable for formation of plasmin by streptokinase. Proceedings Society of Experimental Biology and Medicine 82: 264–268, 1953

    CAS  Google Scholar 

  • Ness PM, Simon TL, Cole C, Walston A. A pilot study of streptokinase therapy in acute myocardial infarction: observations on complications and relation to trial design. American Heart Journal 88: 705–712, 1974

    PubMed  CAS  Google Scholar 

  • Neuhaus KL, Tebbe U, Sauer G, Kreuzer H, Kostering H. High dose intravenous streptokinase in acute myocardial infarction. Clinical Cardiology 6: 426–434, 1983

    PubMed  CAS  Google Scholar 

  • Nolf P. Des modifications de la coagulation du sang chez le chien après extirpation du foie. Archives Internationales Physiologie 3: 1, 1905

    Google Scholar 

  • Nydick I, Ruegsegger P, Bouvier C, Hutter RY, Aberequez R, et al. Salvage of heart muscle by fibrinolytic therapy after experimental coronary occlusion. American Heart Journal 61: 93–100, 1961

    PubMed  CAS  Google Scholar 

  • Opie EL, Barker BI, Dochez AR. Changes in the proteolytic enzymes and anti-enzymes of the blood serum produced by substances (chloroform and phosphorus) which cause degenerative changes in the liver. Journal of Experimental Medicine 13: 162–185, 1911

    PubMed  CAS  Google Scholar 

  • Ploug J, Kjeldgaard NO. Urokinase an activator of plasminogen from human urine. I. Isolation and properties. Biochemica Biophysica Acta. 24: 282–289, 1957

    Google Scholar 

  • Polwoda H, Schneider B, Aenarius HJ. Untersuchungen zum klinischen Verlauf des akuten Myokardinfarktes. Gemeinschaftsstudie an 26 Krankenhäusern in Nord Deutschland. Medizin Klinische 72: 451–58, 1977

    Google Scholar 

  • Reduto LA, Freund GC, Gaeta JM, Smalling RW, Lewis B, Gould KL. Coronary artery reperfusion in acute myocardial infarction: beneficial effects of intracoronary streptokinase on left ventricular salvage and performance. American Heart Journal 102: 1168–1177, 1981

    PubMed  CAS  Google Scholar 

  • Rentrop P, Blanke H, Kostering K, Karsch KR. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase in combination with transluminal recanalisation. Clinical Cardiology 2: 354–363, 1979

    PubMed  CAS  Google Scholar 

  • Roberts WC, Buja LM. The frequency and significance of coronary arterial thrombi and other observations in acute myocardial infarction. American Journal of Medicine 52: 425–444, 1972

    PubMed  CAS  Google Scholar 

  • Sawyer WD, Alkjaersig N, Fletcher AP, Sherry S. Comparison of fibrinolytic and fibrinogenolytic effects of plasminogen activators and proteolotic enzymes in plasma. Thrombosis et Diathesis Haemorrhagica 5: 149–191, 1960

    PubMed  CAS  Google Scholar 

  • Schreiber TL, Miller DH, Silvasi DA, Moses JW, Borer JS. Randomized double-blind trial of intravenous streptokinase for acute myocardial infarction. American Journal of Cardiology 58: 47–52, 1986

    PubMed  CAS  Google Scholar 

  • Schroder R, Biamino G, Enz-Rudiger L, Linderer T, Bruggermann T, et al. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation 63: 536–548, 1983

    Google Scholar 

  • Schuler G, Schwartz F, Hofmann M, Mehmel H, Manthey J, et al. Thrombolysis in acute myocardial infarction using intracoronary streptokinase: Assessment by thallium-201 scintigraphy. Circulation 66: 658–664, 1982

    PubMed  CAS  Google Scholar 

  • Schulman S, Lockner D, Grandquist D, Bratt G, Paul G, Nyman D. A comparative randomized trial of low dose versus high dose streptokinase in deep vein thrombosis of the thigh. Thrombosis and Haemostasis 51: 261–265, 1984

    PubMed  CAS  Google Scholar 

  • Schwarz F, Schuler G, Katus H, Hofmann M, Manthey J, et al. Intracoronary thrombolysis in acute myocardial infarction: Duration of ischaemia as a major determinant of late results after recanalisation. American Journal of Cardiology 50: 933–937, 1982

    PubMed  CAS  Google Scholar 

  • Sheehan FH, Mathey DG, Schofer J, Krebber H-J, Dodge HT. Effect of interventions in salvaging left ventricular function in acute myocardial infarction: a study of intracoronary streptokinase. American Journal of Cardiology 52: 431–438, 1983

    PubMed  CAS  Google Scholar 

  • Sherry S. The fibrinolytic activity of streptokinase activated human plasmin. Journal of Clinical Investigation 35: 1054–1063, 1954

    Google Scholar 

  • Sherry S, Tillett WS. The local use of streptokinase-streptodornase in chronic refractory areas of suppuration with draining sinuses. Annals of Surgery 135: 479–488, 1952

    PubMed  CAS  Google Scholar 

  • Sherry S, Tillett WS, Read CT. The use of streptokinase-streptodornase in the treatment of hemothorax. Journal of Thoracic Surgery 20: 393–417, 1950

    PubMed  CAS  Google Scholar 

  • Sherry S, Titchener A, Gottesman L, Wasserman P, Troll W. Enzymatic dissolution of experimental arterial thrombi in the dog by trypsin, chymotrypsin and plasminogen activators. Journal of Clinical Investigation 33: 1303–1313, 1954

    PubMed  CAS  Google Scholar 

  • Sherry S, Lindemeyer RI, Fletcher AP, Alkjaersig N. Studies on enhanced fibrinolytic activity in man. Journal of Clinical Investigation 38: 810–822, 1959a

    PubMed  CAS  Google Scholar 

  • Sherry S, Fletcher AP, Alkjaersig N. Fibrinolysis and fibrinolytic activity in man. Physiological Reviews 39: 343–382, 1959b

    PubMed  CAS  Google Scholar 

  • Spann JF, Sherry S, Carabello BA, Mann RH, McCann WD, et al. High-dose brief intravenous streptokinase early in acute myocardial infarction. American Heart Journal 104: 939–945, 1982

    PubMed  CAS  Google Scholar 

  • Spann JF, Sherry S, Carabello BA, Denenberg BS, Mann RH, et al. Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: acute and follow-up studies. American Journal of Cardiology 53: 655–661, 1984

    PubMed  CAS  Google Scholar 

  • Stack RS, Phillips HR, Grierson DS, Behar VS, Kong Y, et al. Functional improvement of jeopardised myocardium following intracoronary streptokinase infusion in acute myocardial infarction. Journal of Clinical Investigation 72: 84–95, 1983

    PubMed  CAS  Google Scholar 

  • Stampfer MJ, Goldhaber SZ, Yusuf S, Peto R, Hennekens CH. Effects of intravenous streptokinase on acute myocardial infarction. Results pooled from randomised trials. New England Journal of Medicine 307: 1178–1179, 1982

    Google Scholar 

  • Sutton JM, Taylor GT, Mikell FL, Moses HW, Korsmeyer C, et al. Thrombolytic therapy followed by early revascularization for acute myocardial infarction. American Journal of Cardiology 57: 1227–1231, 1986

    PubMed  CAS  Google Scholar 

  • Symposium. Thrombolytic therapy with streptokinase. Australasian Annals of Medicine 19 (Suppl. 1), 1970

    Google Scholar 

  • Tagnon HJ, Davidson CS, Taylor FHL. The coagulation defect in hemophilia: A comparison of the proteolytic activity of chloroform preparations of hemophilic and normal plasma. Journal of Clinical Investigation 22: 127–129, 1942

    Google Scholar 

  • Taylor GJ, Mikell FL, Moses HW, Dove JT, Batchelder JE, et al. Intravenous versus intracoronary streptokinase for acute myocardial infarction in community hospitals. American Journal of Cardiology 54: 256–260, 1984

    PubMed  CAS  Google Scholar 

  • Tillett WS. The fibrinolytic activity of hemolytic streptococci in relation to the source of strains and to cultural reactions. Journal of Bacteriology 29: 111–130, 1935a

    PubMed  CAS  Google Scholar 

  • Tillett WS. The occurrence of antifibrinolytic properties in the blood of patients with acute hemolytic streptococcus infections. Journal of Clinical Investigation 14: 276–284, 1935b

    PubMed  CAS  Google Scholar 

  • Tillett WS. The fibrinolytic activity of hemolytic streptococci. Bacteriological Reviews 2: 161–216, 1938

    PubMed  CAS  Google Scholar 

  • Tillett WS, Garner RL. The fibrinolytic activity of hemolytic streptococci. Journal of Experimental Medicine 58: 485–502, 1933

    PubMed  CAS  Google Scholar 

  • Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent and sanguinous pleural exudations. Journal of Clinical Investigation 28: 173–190, 1949

    CAS  Google Scholar 

  • Tillett WS, Sherry S, Christensen LR, Johnson A, Hazlehurst G. Streptococcal enzymatic debridement. Annals of Surgery 131: 12–22, 1950

    PubMed  CAS  Google Scholar 

  • Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of postpneumonic empyema. Journal of Thoracic Surgery 21: 275–297, 1951a

    PubMed  CAS  Google Scholar 

  • Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of chronic empyema. Journal of Thoracic Surgery 21: 325–341, 1951b

    PubMed  CAS  Google Scholar 

  • TIMI Study Group. The myocardial infarction (TIMI) trial. Phase

  • I Findings. New England Journal of Medicine 312: 932–936, 1985

    Google Scholar 

  • Troll W, Sherry S. The activation of human plasminogen by streptokinase. Journal of Biological Chemistry 213: 881–891, 1955

    PubMed  CAS  Google Scholar 

  • Urokinase-Pulmonary Embolism Trial Study Group. The urokinase-pulmonary embolism trial. Phase I results. Journal of the American Medical Association 214: 2163–2172, 1970. Circulation 47 (Suppl. II): 1–108, 1973

    Google Scholar 

  • Urokinase-Streptokinase Pulmonary Embolism Trial Study Group. Urokinase-streptokinase pulmonary embolism trial. Phase II results. A national cooperative trial. Journal of the American Medical Association 229: 1606–1613, 1974

    Google Scholar 

  • Valere P-E, Guerot C, Castillo-Fernoy A, et al. L’infarctus myocardique. Traitement randomise par la streptokinase. Nouvelle Presse Medicale 4: 190, 1975

    CAS  Google Scholar 

  • Verstraete M, Tytgat G, Amery A, Vermylen J. Thrombolytic therapy with streptokinase using a standard dosage. Thrombosis et Diathesis Haemorrhagica 16 (Suppl. 21): 494–500, 1966

    Google Scholar 

  • Wischitz S, Kolsky H, Moisson P, Chiche P. Streptokinase et infarctus du myocarde aign. La fibrinolyse peut-elle limiter la necrose? Annales Cardiologique Angelologique 26: 53–56, 1977

    Google Scholar 

  • Yudin SS. Transfusion of cadaver blood. Journal of the American Medical Association 106: 997–999, 1936

    Google Scholar 

  • Yusuf S, Collins R, Peto R, Furberg C, Stampfer MJ, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. European Heart Journal 6: 556–585, 1985

    PubMed  CAS  Google Scholar 

  • Zimmerman (1846) cited by Macfarlane RG, Biggs R. Fibrinolysis. Its mechanism and significance. Blood 3: 1167–1187, 1948.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sherry, S. Thrombolytic Therapy in Acute Myocardial Infarction. Drugs 33 (Suppl 3), 1–12 (1987). https://doi.org/10.2165/00003495-198700333-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198700333-00002

Keywords

Navigation